Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
2.
Acta Biomed ; 91(11-S): e2020003, 2020 09 15.
Article in English | MEDLINE | ID: covidwho-809555

ABSTRACT

n December 2019, in Wuhan (Hubei, China), the first COVID-19 cases due to SARS-COV-2 had been reported. On July 1st 2020, more than 10.268.839 million people had developed the disease, with at least 506.064 deaths. At present, Italy is the third country considering the number of cases (n=240.760), after Spain, and the second for the cumulative number of deaths (n=249.271), after the United States. As regard pediatric COVID-19 cases, more than 4000 cases (have been reported; however, these figures are likely to be underestimated since they are influenced by the number of diagnostic tests carried out. Three pediatric deaths have been reported in Italy to date. We aimed to review the peculiar aspects of SARS-COV-2 infection in the pediatric population.


Subject(s)
Betacoronavirus , Coronavirus Infections/epidemiology , Critical Illness/epidemiology , Pandemics , Pneumonia, Viral/epidemiology , Risk Assessment/methods , COVID-19 , Child , Global Health , Humans , Morbidity/trends , SARS-CoV-2
6.
Ital J Pediatr ; 46(1): 84, 2020 Jun 16.
Article in English | MEDLINE | ID: covidwho-599459

ABSTRACT

The COVID-19 pandemic has surprised the entire population. The world has had to face an unprecedented pandemic. Only, Spanish flu had similar disastrous consequences. As a result, drastic measures (lockdown) have been adopted worldwide. Healthcare service has been overwhelmed by the extraordinary influx of patients, often requiring high intensity of care. Mortality has been associated with severe comorbidities, including chronic diseases. Patients with frailty were, therefore, the victim of the SARS-COV-2 infection. Allergy and asthma are the most prevalent chronic disorders in children and adolescents, so they need careful attention and, if necessary, an adaptation of their regular treatment plans. Fortunately, at present, young people are less suffering from COVID-19, both as incidence and severity. However, any age, including infancy, could be affected by the pandemic.Based on this background, the Italian Society of Pediatric Allergy and Immunology has felt it necessary to provide a Consensus Statement. This expert panel consensus document offers a rationale to help guide decision-making in the management of children and adolescents with allergic or immunologic diseases.


Subject(s)
Allergy and Immunology , Betacoronavirus , Consensus , Coronavirus Infections/therapy , Disease Management , Pandemics , Pneumonia, Viral/therapy , Societies, Medical , Adolescent , COVID-19 , Child , Coronavirus Infections/epidemiology , Decision Making , Humans , Italy/epidemiology , Pneumonia, Viral/epidemiology , Pragmatic Clinical Trials as Topic/methods , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL